The enhanced expression of GIPR on the cancer cell’s surface, and its weaker expression in surrounding healthy tissues underscore this receptors great potential as a molecular target for both imaging and radiation therapy in neuroendocrine tumors [102,103]. This evidence concerns the gene GIPR and neuroendocrine neoplasm.